Course Hero Logo

A aspirin 325 mg chewable b beta blocker given iv c

Course Hero uses AI to attempt to automatically extract content from documents to surface to you and others so you can study better, e.g., in search results, to enrich docs, and more. This preview shows page 235 - 237 out of 838 pages.

a.Aspirin 325 mg chewableb.Beta blocker given IVc.Ibuprofen 400 mg orallyd.Morphine intravenouslyANS: AThis patient shows signs of acute ST-elevation myocardial infarction (STEMI). Because cardiac troponin levelsusually are not detectable until 2 to 4 hours after the onset of symptoms, treatment should begin as symptomsevolve. Chewable aspirin (ASA) should be given immediately to suppress platelet aggregation and produce anantithrombotic effect. Beta blockers are indicated but do not have to be given immediately. Ibuprofen iscontraindicated. Morphine is indicated for pain management and should be administered after aspirin has beengiven.PTS:1DIF:Cognitive Level: ApplicationREF:pp. 626-627TOP:Nursing Process: PlanningMSC:NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies2.A nurse is discussing fibrinolytic therapy for the acute phase of STEMI management with a group of nursingstudents. Which statement by a student indicates understanding of this therapy?a.“Fibrinolytics are effective when the first dose is given up to 24 hours aftersymptom onset.”b.“Fibrinolytics should be given once cardiac troponins reveal the presence ofSTEMI.”c.“Fibrinolytics should be used with caution in patients with a history ofcerebrovascular accident.”d.“Patients should receive either an anticoagulant or an antiplatelet agent with afibrinolytic drug.”ANS: CPatients with a history of cerebrovascular accident (CVA) should not receive fibrinolytic agents because of theincreased risk of intracranial hemorrhage. Fibrinolytics are most effective when given within 30 minutes of arrivalin the emergency department. Because cardiac troponins are not detectable until 2 to 4 hours after the onset ofsymptoms, fibrinolytics should be administered before these laboratory values are available. Patients receivingfibrinolytics should receive both an anticoagulant and an antiplatelet drug.PTS:1DIF:Cognitive Level: AnalysisREF:p. 628TOP:Nursing Process: ImplementationMSC:NCLEX Client Needs Category: Physiologic Integrity: Reduction of Risk Potential3.A nurse is evaluating a patient admitted to the emergency department with an evolving STEMI for possibleadministration of thrombolytic therapy. Which information, identified during history taking, would contraindicatethis type of therapy?a.The patient just completed her last menstrual cycle.b.The patient states that the chest pain started 1 hour ago.c.The patient has a history of a small cerebral aneurysm.d.The patient has hypertension that is well controlled by diuretic therapy.ANS: Co test PDF Combine onlyo test PDF Combine only
Patients with a history of CVA should not receive fibrinolytic therapy. This patient has had a known cerebralaneurysm. Active internal bleeding is a contraindication for thrombolysis except for menses, but the patient hasindicated she has completed her last cycle. Fibrinolytic therapy should be administered for chest pain that has been

Upload your study docs or become a

Course Hero member to access this document

Upload your study docs or become a

Course Hero member to access this document

End of preview. Want to read all 838 pages?

Upload your study docs or become a

Course Hero member to access this document

Term
Spring
Professor
DALUSUNG-ANGOSTA
Tags
Pharmacology, Pharmacologic and Parenteral Therapies, The Grave,

Newly uploaded documents

Show More

Newly uploaded documents

Show More

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture